Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

HepeX-B reduces viral load of patients with chronic HBV infection

Nov. 26, 2004

Merimepodib increases virological response to interferon plus ribavirin therapy in hepatitis C

Nov. 26, 2004

Novel agent by Microbia shows antinociceptive effects in animal models of visceral pain

Nov. 26, 2004

Coumarinolignoid composition for use as hepatoprotective agent described in patent

Nov. 26, 2004

First safety review completed for phase II study of HepeX-B

Nov. 26, 2004

Therapeutic benefits of the Enteryx(R) procedure in GERD

Nov. 25, 2004

Isatoribine reduces HCV viral load in patients with chronic hepatitis C

Nov. 25, 2004

New antioxidants in early development at Japan Science and Technology

Nov. 25, 2004

Cilansetron improves quality of life of patients with diarrhea-predominant IBS

Nov. 24, 2004

New Roche study investigates response rates to HCV therapy in Latinos

Nov. 24, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...